Surrogate decision making of chemotherapy consent: do we really provide informed consent of chemotherapy for patients?

BACKGROUND/AIMS: Despite increased demand for cancer patient’s to make their own decisions based on an adequate understanding of what is involved in chemotherapy, the primary signing agent and the reasons for surrogate signing have not been appropriately evaluated. METHODS: The ethics committee of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Jung Hye, Baek, Sun Kyung, Kim, Bong-Seog, Koh, Su-Jin, Ahn, Hee Kyung, Lim, Joo Han, Lim, Chiyeon, Kim, Do Yeun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506731/
https://www.ncbi.nlm.nih.gov/pubmed/29843493
http://dx.doi.org/10.3904/kjim.2017.252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506731/
https://www.ncbi.nlm.nih.gov/pubmed/29843493
http://dx.doi.org/10.3904/kjim.2017.252

Ejemplares similares